Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography -: art. no. 044019

被引:38
作者
Graves, EE
Yessayan, D
Turner, G
Weissleder, R
Ntziachristos, V
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res,Dept Radiol, Charlestown, MA 02129 USA
关键词
fluorescence molecular tomography; fluorescent probes; diffuse optical tomography; molecular imaging;
D O I
10.1117/1.1993427
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Fluorescence molecular tomography (FMT) has emerged as a means of quantitatively imaging fluorescent molecular probes in three dimensions in living systems. To assess the accuracy of FMT in vivo, translucent plastic tubes containing a turbid solution with a known concentration of Cy 5.5 fluorescent dye are constructed and implanted subcutaneously in nude mice, simulating the presence of a tumor accumulating a fluorescent molecular reporter. Comparisons between measurements of fluorescent tubes made before and after implantation demonstrate that the accuracy of FMT reported for homogeneous phantoms extends to the in vivo situation. The sensitivity of FMT to background fluorescence is tested by imaging fluorescent tubes in mice injected with Cy 5.5-labeled Annexin V. For small tube fluorochrome concentrations, the presence of background fluorescence results in increases in the reconstructed concentration. This phenomenon is counteracted by applying a simple subtraction correction to the measured fluorescence data. The effects of varying tumor photon absorption are simulated by imaging fluorescent tubes with varying ink concentrations, and are found to be minor. These findings demonstrate the in vivo quantitative accuracy of fluorescence tomography, and encourage further development of this imaging modality as well as application of FMT in molecular imaging studies using fluorescent reporters. (C) 2005 Society of Photo-Optical Instrumentation Engineers.
引用
收藏
页数:10
相关论文
共 45 条
[1]   Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging [J].
Achilefu, S ;
Dorshow, RB ;
Bugaj, JE ;
Rajagopalan, R .
INVESTIGATIVE RADIOLOGY, 2000, 35 (08) :479-485
[2]   Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands [J].
Becker, A ;
Hessenius, C ;
Licha, K ;
Ebert, B ;
Sukowski, U ;
Semmler, W ;
Wiedenmann, B ;
Grötzinger, C .
NATURE BIOTECHNOLOGY, 2001, 19 (04) :327-331
[3]   Near-infrared (NIR) tomography breast image reconstruction with a priori structural information from MRI:: Algorithm development for reconstructing heterogeneities [J].
Brooksby, BA ;
Dehghani, H ;
Pogue, BW ;
Paulsen, KD .
IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS, 2003, 9 (02) :199-209
[4]   Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform [J].
Bugaj, JE ;
Achilefu, S ;
Dorshow, RB ;
Rajagopalan, R .
JOURNAL OF BIOMEDICAL OPTICS, 2001, 6 (02) :122-133
[5]   Imaging of fluorescence in highly scattering media [J].
Chang, JH ;
Graber, HL ;
Barbour, RL .
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 1997, 44 (09) :810-822
[6]  
Dellian M, 2000, BRIT J CANCER, V82, P1513
[7]   Three-dimensional, Bayesian image reconstruction from sparse and noisy data sets: Near-infrared fluorescence tomography [J].
Eppstein, MJ ;
Hawrysz, DJ ;
Godavarty, A ;
Sevick-Muraca, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9619-9624
[8]  
FOLLI S, 1994, CANCER RES, V54, P2643
[9]   Fluorescence-enhanced optical imaging in large tissue volumes using a gain-modulated ICCD camera [J].
Godavarty, A ;
Eppstein, MJ ;
Zhang, CY ;
Theru, S ;
Thompson, AB ;
Gurfinkel, M ;
Sevick-Muraca, EM .
PHYSICS IN MEDICINE AND BIOLOGY, 2003, 48 (12) :1701-1720
[10]  
Gonzalez Salvador, 1999, Journal of Medicine (Westbury), V30, P337